Title : [Outcomes of refractory or relapsed DNMT3A + cytogenetically normal acute myeloid leukemia patients followed the therapy including decitabine combined with CAG or CAG-like regimen].

Pub. Date : 2015 Dec

PMID : 26759106






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 DNMT3A+/FLT3-ITD+ CN-AML patients(n=14)had higher ORR and CR rates than DNMT3A-/FLT3-ITD+CN- AML patients(n=15)(P= 0.040 and 0.042, respectively). Chromium DNA methyltransferase 3 alpha Homo sapiens
2 Compared to DNMT3A-/FLT3- ITD+ CN- AML patients, DNMT3A+/ FLT3-ITD+ CN-AML patients had higher ORR and CR rates. Chromium DNA methyltransferase 3 alpha Homo sapiens